284 related articles for article (PubMed ID: 28463521)
1. Metabolic PET Imaging in Oncology.
Sai KKS; Zachar Z; Bingham PM; Mintz A
AJR Am J Roentgenol; 2017 Aug; 209(2):270-276. PubMed ID: 28463521
[TBL] [Abstract][Full Text] [Related]
2. [Understanding positon emission tomography (PET) with [18F]-FDG in clinical oncology. Informations dedicated to patients and relatives].
Bourguet P; Brusco S; Corone C; Devillers A; Foehrenbach H; Lumbroso JD; Maszelin P; Montravers F; Moretti JL; Rain JD; Talbot JN; Carretier J; Leichtnam-Dugarin L; Delavigne V; Philip T; Fervers B; ; ; ; ; ; ;
Bull Cancer; 2005 Jul; 92(7):723-32. PubMed ID: 16123010
[TBL] [Abstract][Full Text] [Related]
3. [Oncology PET imaging].
Inubushi M
Igaku Butsuri; 2014; 34(1):3-9. PubMed ID: 25199271
[TBL] [Abstract][Full Text] [Related]
4. Revisit 18F-fluorodeoxyglucose oncology positron emission tomography: "systems molecular imaging" of glucose metabolism.
Shen B; Huang T; Sun Y; Jin Z; Li XF
Oncotarget; 2017 Jun; 8(26):43536-43542. PubMed ID: 28402949
[TBL] [Abstract][Full Text] [Related]
5. PET-CT in oncology.
Purandare NC; Rangarajan V
J Postgrad Med; 2010; 56(2):103-8. PubMed ID: 20622389
[TBL] [Abstract][Full Text] [Related]
6. Advances in metabolic imaging for surgical oncology.
Iagaru A; Quon A
Surg Oncol Clin N Am; 2007 Apr; 16(2):273-92. PubMed ID: 17560512
[TBL] [Abstract][Full Text] [Related]
7. (18)F-labeled positron emission tomographic radiopharmaceuticals in oncology: an overview of radiochemistry and mechanisms of tumor localization.
Vallabhajosula S
Semin Nucl Med; 2007 Nov; 37(6):400-19. PubMed ID: 17920348
[TBL] [Abstract][Full Text] [Related]
8. FDG and Beyond.
De Ruysscher D; Haustermans K; Thorwarth D
Recent Results Cancer Res; 2016; 198():163-73. PubMed ID: 27318686
[TBL] [Abstract][Full Text] [Related]
9. Application of metabolic PET imaging in radiation oncology.
Zhu A; Marcus DM; Shu HK; Shim H
Radiat Res; 2012 Apr; 177(4):436-48. PubMed ID: 22339451
[TBL] [Abstract][Full Text] [Related]
10. Non-[18F]FDG PET in clinical oncology.
Groves AM; Win T; Haim SB; Ell PJ
Lancet Oncol; 2007 Sep; 8(9):822-30. PubMed ID: 17765191
[TBL] [Abstract][Full Text] [Related]
11. Imaging of Tumor Metabolism Using Positron Emission Tomography (PET).
Apostolova I; Wedel F; Brenner W
Recent Results Cancer Res; 2016; 207():177-205. PubMed ID: 27557539
[TBL] [Abstract][Full Text] [Related]
12. Metabolic positron emission tomography imaging in cancer detection and therapy response.
Zhu A; Lee D; Shim H
Semin Oncol; 2011 Feb; 38(1):55-69. PubMed ID: 21362516
[TBL] [Abstract][Full Text] [Related]
13. Benign variations and incidental abnormalities of myocardial FDG uptake in the fasting state as encountered during routine oncology positron emission tomography studies.
Fukuchi K; Ohta H; Matsumura K; Ishida Y
Br J Radiol; 2007 Jan; 80(949):3-11. PubMed ID: 17005513
[TBL] [Abstract][Full Text] [Related]
14. Update on advances in molecular PET in urological oncology.
Kitajima K; Yamamoto S; Fukushima K; Minamimoto R; Kamai T; Jadvar H
Jpn J Radiol; 2016 Jul; 34(7):470-85. PubMed ID: 27222021
[TBL] [Abstract][Full Text] [Related]
15. 18FDG PET in oncology: the best and the worst (Review).
Belhocine T; Spaepen K; Dusart M; Castaigne C; Muylle K; Bourgeois P; Bourgeois D; Dierickx L; Flamen P
Int J Oncol; 2006 May; 28(5):1249-61. PubMed ID: 16596242
[TBL] [Abstract][Full Text] [Related]
16. Clinical applications of positron emission tomography in sarcoma management.
Quak E; van de Luijtgaarden AC; de Geus-Oei LF; van der Graaf WT; Oyen WJ
Expert Rev Anticancer Ther; 2011 Feb; 11(2):195-204. PubMed ID: 21342039
[TBL] [Abstract][Full Text] [Related]
17. False-positive uptake on 2-[¹⁸F]-fluoro-2-deoxy-D-glucose (FDG) positron-emission tomography/computed tomography (PET/CT) in oncological imaging.
Culverwell AD; Scarsbrook AF; Chowdhury FU
Clin Radiol; 2011 Apr; 66(4):366-82. PubMed ID: 21356398
[TBL] [Abstract][Full Text] [Related]
18. [Hybrid PET/CT in cancer imaging].
Seppänen M; Kajander S; Kemppainen J; Minn H
Duodecim; 2011; 127(11):1117-27. PubMed ID: 21755803
[TBL] [Abstract][Full Text] [Related]
19. Whole-body MRI and FDG PET fused images for evaluation of patients with cancer.
Domingues RC; Carneiro MP; Lopes FC; Domingues RC; da Fonseca LM; Gasparetto EL
AJR Am J Roentgenol; 2009 Apr; 192(4):1012-20. PubMed ID: 19304708
[TBL] [Abstract][Full Text] [Related]
20. Clinical molecular imaging with positron emission tomography.
Saleem A; Charnley N; Price P
Eur J Cancer; 2006 Aug; 42(12):1720-7. PubMed ID: 16797972
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
